Tissue Regenix Group "has the opportunity to become a global commercial organisation" - Danny Lee, CEO, Tissue Regenix Group 00:00:00

Share On Facebook Share On Twitter

Tissue Regenix Group PLC (AIM:TRX, OTC:TSSNF) chief executive Danny Lee and chief financial officer David Cocke speak to Proactive's Thomas Warner after releasing a trading update for 2022.

Recent Videos